Revumenib Shows Promise for Advanced Acute Myeloid Leukemia - NCI
Por um escritor misterioso
Descrição
In the AUGMENT-101 trial, treatment with revumenib caused complete remission in about one-third of participants, all of whom had many prior treatments. The targeted therapy is part of a new class of drugs known as menin inhibitors.
Nicole Stephens, PhD, CCRP, CLSSGB posted on LinkedIn
Clinical Trial Results - Cancer Currents Blog - NCI
Juan Manuel Pérez Huacuja Urista posted on LinkedIn
National Cancer Institute (NCI) on LinkedIn: #melanoma
Clinical Trial Results National Cancer Institute
Medical Advances in Leukemia Research
National Cancer Institute (NCI) on LinkedIn: #ncifuture
Treatment - Cancer Currents Blog - NCI
I-131 apamistamab induces response among adults with advanced
Treatment National Cancer Institute
de
por adulto (o preço varia de acordo com o tamanho do grupo)
